You are here

Article info

Article menu

This article has a Reply. Please see:

Download PDFPDF

Correspondence
COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs
Free

Authors

  • Khalil Ansarin Rahat Breath and Sleep Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran PubMed articlesGoogle scholar articles
  • Ali Taghizadieh Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran PubMed articlesGoogle scholar articles
  • Saeid Safiri Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran Department of Community Medicine, School of Medicine, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran PubMed articlesGoogle scholar articles
  • Aida Malek Mahdavi Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran PubMed articlesGoogle scholar articles
  • Shirin Ranjbar Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran PubMed articlesGoogle scholar articles
  • Soheil Teymouri Department of Internal Medicine, School of Medicine, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran PubMed articlesGoogle scholar articles
  • Masoud Ahangari Maleki Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran PubMed articlesGoogle scholar articles
  • Alireza Khabbazi Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Alireza Khabbazi, Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan 5166614756, Iran; dr_khabbazi{at}yahoo.com
View Full Text

Citation

Ansarin K, Taghizadieh A, Safiri S, et al
COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs
Annals of the Rheumatic Diseases 2022;81:e190.

Publication history

  • Received July 29, 2020
  • Accepted July 30, 2020
  • First published August 5, 2020.
Online issue publication 
September 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage